Roche Holding AG (OTCMKTS:RHHBY) Receives $60.00 Average PT from Analysts

Roche Holding AG (OTCMKTS:RHHBY) has received a consensus recommendation of “Hold” from the eleven brokerages that are currently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $60.00.

Several research analysts have weighed in on the stock. Morgan Stanley upgraded shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 target price on the stock in a research report on Friday, August 7th. Zacks Research upgraded shares of Roche from a “strong sell” rating to a “hold” rating in a research report on Monday, August 24th. Finally, HSBC lowered Roche from a “buy” rating to a “hold” rating in a research note on Monday, July 6th.

Institutional Trading of Roche

A number of institutional investors have recently bought and sold shares of the company. Renasant Bank acquired a new stake in Roche in the second quarter valued at $210,000. North Star Asset Management Inc. acquired a new position in shares of Roche during the 2nd quarter worth $1,351,000. Puzo Michael J purchased a new stake in shares of Roche in the 2nd quarter worth about $1,229,000. Fulton Bank N.A. boosted its position in shares of Roche by 5.1% in the 2nd quarter. Fulton Bank N.A. now owns 11,572 shares of the company’s stock worth $597,000 after buying an additional 559 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in Roche by 14.3% in the 2nd quarter. GAMMA Investing LLC now owns 29,015 shares of the company’s stock valued at $1,490,000 after acquiring an additional 3,625 shares during the last quarter.

Roche Stock Performance

Shares of RHHBY opened at $55.19 on Monday. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72. Roche has a 52-week low of $39.50 and a 52-week high of $60.85. The company has a 50-day simple moving average of $53.94 and a 200-day simple moving average of $52.92.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.